Should atenolol still be recommended as first-line therapy for primary hypertension?
Karagiannis
Asterios
A
Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece. astkar@med.auth.gr
Athyros
Vasilios G
VG
Papageorgiou
Athanasios
A
Tziomalos
Konstantinos
K
Elisaf
Moses
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
D000319:Adrenergic beta-Antagonists; D001262:Atenolol